The Centers for Disease Control and Prevention (CDC) on Monday warned that a deadly fungus called Candida auris (C. auris) is spreading at an "alarming rate" in the U.S. healthcare facilities.
“The rapid rise and geographic spread of cases is concerning and emphasizes the need for continued surveillance, expanded lab capacity, quicker diagnostic tests, and adherence to proven infection prevention and control,” said CDC epidemiologist Dr. Meghan Lyman, lead author of the paper, in a press release.
Adding to the agency's concerns, the number of infections that were resistant to echinocandins, which is the antifungal medicine most commonly used to treat C. auris infections, tripled in 2021.
The CDC classified C. auris as an "urgent antimicrobial resistance (AR) threat," meaning "it is often resistant to multiple antifungal drugs, spreads easily in healthcare facilities, and can cause severe infections with high death rates."
Between 2016, when C. auris was first reported, and 2021, there have been a total of 3,270 clinical cases reported and 7,413 screening cases.
The agency said "poor general infection prevention and control (IPC) practices in healthcare facilities" are responsible for the spread. However, expanded efforts to detect cases is also responsible for the jump in reported cases.
Clive McCoy, director of tourism for the British Virgin Islands, joined Cheddar to discuss how the territory was relaxing restrictions for travel to resume back to the tropical getaway.
While much of the world remains hunkered down, the band Six60 has been playing to huge crowds in New Zealand, where social distancing isn’t required after the nation stamped out the coronavirus.
The charitable arm of San Francisco-based technology giant Cisco Systems has pledged to invest $100 million over the next decade to help reverse the impact of climate change.
The White House says the U.S. will begin sharing its entire stock of AstraZeneca COVID-19 vaccines with the world once it clears federal safety reviews.
Officials say the European Union is finalizing plans to allow tourists from the United States to travel to the 27-nation bloc this summer.
Jill is joined by Baker Machado this morning to talk about the CDC reinstating the J&J vaccine, a worsening Coronavirus crisis in India, but also, where things are looking a lot better.
Michigan has become the current national hotspot for COVID-19 infections and hospitalizations at a time when more than half the U.S. adult population has been vaccinated and other states have seen the virus diminish substantially.
A U.S. health panel says it’s time to resume use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots.
A growing coalition of private companies, nonprofits, and the federal government are pushing for a more unified approach towards COVID vaccination credentialing.
World leaders have joined President Joe Biden at a virtual climate summit to share their stories about how nations can break free of climate-damaging fossil fuels.
